Drug Combination Details
General Information of the Combination (ID: C40727) | |||||
---|---|---|---|---|---|
Name | Paclitaxel NP Info | + | Cisplatin Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Ovarian cancer
[ICD-11: 2C73]
|
Phase 3 | [1] | ||
Colorectal cancer
[ICD-11: 2B91]
|
Investigative | [2] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [2] | |||||
In-vitro Model | LoVo | CVCL_0399 | Colon adenocarcinoma | Homo sapiens | ||
Experimental
Result(s) |
Paclitaxel in combination with cisplatin showed the most cytotoxic effect in colorectal cancer cells. |
